1. fire cracker fire cracker Australia says:

    Alnylam have the wherewithal to commercialise their successful products. Neither Gradalis or Benitec Biopharma can match that which makes them both risky propositions until they get Phase lll results.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.